Boston Scientific Corporation And Johnson & Johnson Shares Off On Stent Worries
CHICAGO, June 22 (Reuters) - Shares of stent makers Boston Scientific Corp. (BSX.N: Quote, Profile, Research) and Johnson & Johnson (JNJ.N: Quote, Profile, Research) fell on Thursday following a published report that the use of drug-coated stents is declining because of safety concerns.